Joan Blade

Author PubWeight™ 21.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Blood 2011 4.00
2 Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood 2011 2.72
3 Long-term prognostic significance of response in multiple myeloma after stem cell transplantation. Blood 2011 2.58
4 Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J 2003 1.81
5 Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations. Hematol J 2002 1.72
6 Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group. Blood 2008 1.68
7 Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens. Blood 2009 1.59
8 Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia. Blood 2006 1.51
9 Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study. Br J Haematol 2013 0.91
10 Management of complications in multiple myeloma. Semin Hematol 2009 0.88
11 T1 mapping: characterisation of myocardial interstitial space. Insights Imaging 2014 0.86
12 Myeloablative treatments for multiple myeloma: update of a comparative study of different regimens used in patients from the Spanish registry for transplantation in multiple myeloma. Leuk Lymphoma 2002 0.81
13 Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopenia. Eur J Haematol 2011 0.77
14 The future role of thalidomide in multiple myeloma. Acta Haematol 2005 0.75